21 – 30 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Reprogramming Stars #23 : Charting Cell Fate Crossroads from the Interplay Between Epigenetics, Transcription, and 3D Chromatin Architecture-An Interview with Dr. Effie Apostolou
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
(2025) In Journal of visualized experiments : JoVE
- Contribution to journal › Article
- 2024
-
Mark
Of gains and losses : SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
- Contribution to journal › Scientific review
-
Mark
New sickle cell disease drug approved for use in England – here’s how voxelotor works
(2024) In The Conversation
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
- Contribution to journal › Article
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
- Contribution to journal › Debate/Note/Editorial
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
- Contribution to journal › Published meeting abstract
-
Mark
The Impact of Senescent Cells on Limb Regeneration
- Contribution to journal › Debate/Note/Editorial
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
Osteopontin : A Key Multifaceted Regulator in Tumor Progression and Immunomodulation
- Contribution to journal › Scientific review
